Abstract EP658 Table 1

Demographics and baseline treatment details, compared with chemo-irradiation subgroup of PORTEC-3

Tuen Mun Data (n=25)PORTEC-3 (chemo-irradiation subgroup; n=330)
Median age (year) 55 62
Stage III (%) 88 46
Histology (%) Endometrioid grade 1–2 40 40
Endometrioid grade 3 32 27
Serous 8 16
Clear cell 0 9
Mixed 8 5
Others 12 4
Lymph node dissection >12 lymph nodes (%) 76 57